Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care.

[1]  A. Humar,et al.  Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice , 2019, Clinical transplantation.

[2]  G. Ewald,et al.  Noninvasive detection of graft injury after heart transplant using donor‐derived cell‐free DNA: A prospective multicenter study , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[3]  L. Potena,et al.  An integrated molecular diagnostic report for heart transplant biopsies using an ensemble of diagnostic algorithms. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  A. Clark,et al.  Identification of Frailty in Chronic Heart Failure. , 2019, JACC. Heart failure.

[5]  Deepali Kumar,et al.  Marijuana use in transplantation: A call for clarity , 2019, Clinical transplantation.

[6]  Y. Nakamura,et al.  Successful Heart Transplantation After Desensitization in a Patient With Extremely High Panel-Reactive Antibody Levels and Pretransplant Donor-Specific Antibody: A Case Report. , 2018, Transplantation proceedings.

[7]  A. Angelini,et al.  MicroRNA signatures in cardiac biopsies and detection of allograft rejection. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  J. Garbade,et al.  The clinical impact of donor-specific antibodies in heart transplantation. , 2018, Transplantation reviews.

[9]  M. Fishbein,et al.  Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients , 2018, Transplantation.

[10]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth Adult Heart Transplantation Report-2018; Focus Theme: Multiorgan Transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  M. Zembala,et al.  Speckle-Tracking Echocardiography for Monitoring Acute Rejection in Transplanted Heart. , 2018, Transplantation proceedings.

[12]  Sanjiv J. Shah,et al.  Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy , 2018, The New England journal of medicine.

[13]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  S. Restaino,et al.  Outcomes associated with mammalian target of rapamycin (mTOR) inhibitors in heart transplant recipients: A meta-analysis. , 2018, International journal of cardiology.

[15]  J. Friedewald,et al.  Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  M. Dew,et al.  The 2018 ISHLT/APM/AST/ICCAC/STSW recommendations for the psychosocial evaluation of adult cardiothoracic transplant candidates and candidates for long-term mechanical circulatory support. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  K. Khush,et al.  New Horizons on the 50th Anniversary of Heart Transplantation in Canada: "Where There Is Death, There Is Hope". , 2018, Canadian Journal of Cardiology.

[18]  G. Wells,et al.  PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy. , 2018, Journal of the American College of Cardiology.

[19]  T. Cascino,et al.  Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes , 2018, Annals of Internal Medicine.

[20]  I. V. Van Gelder,et al.  Cardiac resynchronization therapy in adults with congenital heart disease , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[21]  C. Silversides,et al.  Phenotype, management and predictors of outcome in a large cohort of adult congenital heart disease patients with heart failure. , 2018, International journal of cardiology.

[22]  Akshay S. Desai,et al.  Diagnostic and prognostic value of myocardial blood flow quantification as non-invasive indicator of cardiac allograft vasculopathy , 2018, European heart journal.

[23]  L. Lund,et al.  Temporal Trends of De Novo Malignancy Development After Heart Transplantation. , 2018, Journal of the American College of Cardiology.

[24]  H. Ross,et al.  Peri-operative desensitization for highly sensitized heart transplant patients. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[25]  P. Reinke,et al.  Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: Long-term Results After 7 Years of a Randomized Clinical Trial , 2017, Transplantation.

[26]  J. Goldsmith,et al.  Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty? , 2017, Journal of the American Geriatrics Society.

[27]  B. Bergmark,et al.  Early aspirin use and the development of cardiac allograft vasculopathy. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[28]  P. Macdonald,et al.  Handle with care: A systematic review on frailty in cardiac care and its usefulness in heart transplantation. , 2017, Transplantation reviews.

[29]  A. Yeung,et al.  Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation. , 2017, Journal of the American College of Cardiology.

[30]  M. Guglin,et al.  Heart transplantation in cardiac amyloidosis , 2017, Heart Failure Reviews.

[31]  K. Olthoff,et al.  Single‐center outcomes of combined heart and liver transplantation in the failing Fontan , 2017, Clinical transplantation.

[32]  J. Stein,et al.  Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States , 2017, JAMA dermatology.

[33]  M. de Pauw,et al.  The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial , 2017, Journal of transplantation.

[34]  C. Daniels,et al.  Isolated heart transplant and combined heart-liver transplant in adult congenital heart disease patients: Insights from the united network of organ sharing. , 2017, International journal of cardiology.

[35]  S. Kim,et al.  Cancer Screening Recommendations for Solid Organ Transplant Recipients: A Systematic Review of Clinical Practice Guidelines , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  A. Althouse,et al.  Perioperative mortality is the Achilles heel for cardiac transplantation in adults with congenital heart disease: Evidence from analysis of the UNOS registry , 2016, Journal of cardiac surgery.

[37]  D. Mancini,et al.  The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. , 2016, JACC. Heart failure.

[38]  L. Voska,et al.  Safety and Efficacy of Immunoadsorption in Heart Transplantation Program. , 2016, Transplantation proceedings.

[39]  P. Macdonald,et al.  Cognitive impairment improves the predictive validity of physical frailty for mortality in patients with advanced heart failure referred for heart transplantation. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[40]  G. Felker,et al.  Pulmonary Hypertension in the Era of Mechanical Circulatory Support , 2016, ASAIO journal.

[41]  E. Blackstone,et al.  Does Survival on the Heart Transplant Waiting List Depend on the Underlying Heart Disease? , 2016, JACC. Heart failure.

[42]  T. Roberts,et al.  High on Cannabis and Calcineurin Inhibitors: A Word of Warning in an Era of Legalized Marijuana , 2016, Case reports in transplantation.

[43]  S. Jordan,et al.  Six‐year outcomes in broadly HLA‐sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab , 2016, Transplant international : official journal of the European Society for Organ Transplantation.

[44]  H. Ishibashi-Ueda,et al.  Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis , 2016, Transplantation.

[45]  E. Bacha,et al.  Outcomes of Adult Patients With Congenital Heart Disease After Heart Transplantation: Impact of Disease Type, Previous Thoracic Surgeries, and Bystander Organ Dysfunction. , 2016, Journal of cardiac failure.

[46]  A. Yeung,et al.  Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation , 2016, Circulation.

[47]  J. Pirk,et al.  Non-Fontan Adult Congenital Heart Disease Transplantation Survival Is Equivalent to Acquired Heart Disease Transplantation Survival. , 2016, The Annals of thoracic surgery.

[48]  C. Schmults,et al.  Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer. , 2016, JAMA dermatology.

[49]  Adrian F. Hernandez,et al.  Trends and outcomes of patients with adult congenital heart disease and pulmonary hypertension listed for orthotopic heart transplantation in the United States. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[50]  A. Ducharme,et al.  Multicenter evaluation of a national organ sharing policy for highly sensitized patients listed for heart transplantation in Canada. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[51]  C. Shun,et al.  Malignancy After Heart Transplantation Under Everolimus Versus Mycophenolate Mofetil Immunosuppression. , 2016, Transplantation proceedings.

[52]  L. Iserin,et al.  Temporal trends and changing profile of adults with congenital heart disease undergoing heart transplantation. , 2016, European heart journal.

[53]  Heather J Ross,et al.  Transplantation and Mechanical Circulatory Support in Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[54]  F. Cimino,et al.  Primary Care of the Solid Organ Transplant Recipient , 2016, American family physician.

[55]  P. Leprince,et al.  Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II , 2016, European heart journal.

[56]  L. Goldraich,et al.  Retransplant and Medical Therapy for Cardiac Allograft Vasculopathy: International Society for Heart and Lung Transplantation Registry Analysis , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[57]  R. Benza,et al.  Pulmonary hypertension in potential heart transplant recipients: current treatment strategies , 2015, Current opinion in organ transplantation.

[58]  J. Felblinger,et al.  Design of the DRAGET Study: a multicentre controlled diagnostic study to assess the detection of acute rejection in patients with heart transplant by means of T2 quantification with MRI in comparison to myocardial biopsies , 2015, BMJ Open.

[59]  T. Schuster,et al.  Prognostic Value of Plasma B-Type Natriuretic Peptide in the Long-Term Follow-up of Patients With Transposition of the Great Arteries With Morphologic Right Systemic Ventricle After Atrial Switch Operation. , 2015, Circulation journal : official journal of the Japanese Circulation Society.

[60]  G. Felker,et al.  Cardiac transplantation for older patients: Characteristics and outcomes in the septuagenarian population. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[61]  M. Walsh,et al.  Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. , 2015, Journal of cardiac failure.

[62]  R. Cheng,et al.  Randomized Pilot Trial of Gene Expression Profiling Versus Heart Biopsy in the First Year After Heart Transplant: Early Invasive Monitoring Attenuation Through Gene Expression Trial , 2015, Circulation. Heart failure.

[63]  M. Desai,et al.  Dobutamine stress echocardiography during follow-up surveillance in heart transplant patients: Diagnostic accuracy and predictors of outcomes. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[64]  Richard B. Thompson,et al.  Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[65]  H. Ross,et al.  Outcomes in adult congenital heart disease patients undergoing heart transplantation: A systematic review and meta-analysis. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[66]  K. Mandal,et al.  The survival benefit of simultaneous heart-kidney transplantation extends beyond dialysis-dependent patients. , 2015, The Annals of thoracic surgery.

[67]  J. Kobashigawa,et al.  Terminal Complement Inhibition for Highly Sensitized Patients Undergoing Heart Transplantation - Doable? , 2015 .

[68]  R. Alloway,et al.  Prospective Iterative Trial of Proteasome Inhibitor‐Based Desensitization , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[69]  J. Fillaux,et al.  Risk Factors of Pneumocystis Pneumonia in Solid Organ Recipients in the Era of the Common Use of Posttransplantation Prophylaxis , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[70]  C. Gleissner,et al.  Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy , 2014, Drug design, development and therapy.

[71]  D. Bernstein,et al.  HLA desensitization with bortezomib in a highly sensitized pediatric patient , 2014, Pediatric transplantation.

[72]  X. Jouven,et al.  MicroRNAs as non-invasive biomarkers of heart transplant rejection. , 2014, European heart journal.

[73]  T. Wozniak,et al.  Recipient body mass index and age interact to impact survival after heart transplantation , 2014, Clinical transplantation.

[74]  H. Ross,et al.  Impact Of Adult Congenital Heart Disease ( Achd ) On Survival And Mortality After Heart Transplantation ( Htx ) , 2014 .

[75]  Hee-Jin Kim,et al.  Bortezomib, melphalan, and prednisolone combination chemotherapy for newly diagnosed light chain (AL) amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[76]  T. Kovacsovics,et al.  Induction bortezomib in Al amyloidosis followed by high dose melphalan and autologous stem cell transplantation: a single institution retrospective study. , 2014, Clinical lymphoma, myeloma & leukemia.

[77]  Zhezhen Jin,et al.  Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database). , 2014, The American journal of cardiology.

[78]  L. Leibovici,et al.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. , 2014, The Cochrane database of systematic reviews.

[79]  G. Dellgren,et al.  Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[80]  J. Azzi,et al.  Long-Term Outcomes of Kidney Transplantation Across a Positive Complement-Dependent Cytotoxicity Crossmatch , 2014, Transplantation.

[81]  M. Ligowski,et al.  Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. , 2014, Annals of Transplantation.

[82]  Daniel Bernstein,et al.  Circulating Cell-Free DNA Enables Noninvasive Diagnosis of Heart Transplant Rejection , 2014, Science Translational Medicine.

[83]  B. Barrett,et al.  Screening strategies for cardiovascular disease in asymptomatic adults. , 2014, Primary care.

[84]  Stavros G Drakos,et al.  Coronary computed tomography angiography for the detection of cardiac allograft vasculopathy: a meta-analysis of prospective trials. , 2014, Journal of the American College of Cardiology.

[85]  A. Husain,et al.  Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis , 2014, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[86]  G. Ewald,et al.  A multi-institutional study of malignancies after heart transplantation and a comparison with the general United States population. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[87]  Ahmad Y. Sheikh,et al.  Heart transplantation with or without prior mechanical circulatory support in adults with congenital heart disease. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[88]  Adrian K. Dyer,et al.  High-Sensitivity Cardiac Troponin I Assay to Screen for Acute Rejection in Patients With Heart Transplant , 2014, Circulation. Heart failure.

[89]  G. Gregoraci,et al.  Steroid-free and steroid withdrawal protocols in heart transplantation: the review of literature , 2014, Transplant international : official journal of the European Society for Organ Transplantation.

[90]  R. Witteles,et al.  Changing outcomes after heart transplantation in patients with amyloid cardiomyopathy. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[91]  M. Wheeler,et al.  Outcomes After Heart Transplantation for Amyloid Cardiomyopathy in the Modern Era , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[92]  D. Driscoll,et al.  Cardiac and multiorgan transplantation for end-stage congenital heart disease. , 2014, Mayo Clinic proceedings.

[93]  H. Mallidi,et al.  Combined Heart–Liver Transplantation in the MELD Era: Do Waitlisted Patients Require Exception Status? , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[94]  H. Mallidi,et al.  Heart and Combined Heart–Kidney Transplantation in Patients With Concomitant Renal Insufficiency and End‐Stage Heart Failure , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[95]  D. Seldin,et al.  Predictors of survival to orthotopic heart transplant in patients with light chain amyloidosis. , 2014, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[96]  N. Cimino,et al.  Exogenous cannabinoids as substrates, inhibitors, and inducers of human drug metabolizing enzymes: a systematic review , 2014, Drug metabolism reviews.

[97]  O. Tutarel,et al.  Prognostic value of NT-proBNP in patients with systemic morphological right ventricles: a single-centre experience. , 2013, International journal of cardiology.

[98]  James O. Mudd,et al.  Organ allocation in adults with congenital heart disease listed for heart transplant: impact of ventricular assist devices. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[99]  R. Starling,et al.  Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial. , 2013, JACC. Heart failure.

[100]  Josef Stehlik,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report--2013; focus theme: age. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[101]  L. Lerman,et al.  Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[102]  A. Evens,et al.  Post-Transplant Lymphoproliferative Disease (PTLD): Risk Factors, Diagnosis, and Current Treatment Strategies , 2013, Current Hematologic Malignancy Reports.

[103]  C. Sergi,et al.  Malignancy after Heart Transplantation: A Systematic Review of the Incidence and Risk Factors Compared with Other Solid Organ Transplants , 2013 .

[104]  G. Ewald,et al.  Everolimus Versus Mycophenolate Mofetil in Heart Transplantation: A Randomized, Multicenter Trial , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[105]  H. Ross,et al.  A Survey of Current Practice for Antibody‐Mediated Rejection in Heart Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[106]  B. Meiser,et al.  Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[107]  B. Meiser,et al.  Ten-Year Results of a Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After Heart Transplantation , 2013, Transplantation.

[108]  Dionne A. Graham,et al.  MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery , 2013, Heart.

[109]  Nader Moazami,et al.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. , 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[110]  H. Mallidi,et al.  Heart transplant graft survival is improved after a reduction in panel reactive antibody activity. , 2013, The Journal of thoracic and cardiovascular surgery.

[111]  M. Raftery,et al.  A Surveillance Model for Skin Cancer in Organ Transplant Recipients: A 22‐Year Prospective Study in an Ethnically Diverse Population , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[112]  G. Berry,et al.  Concordance Among Pathologists in the Second Cardiac Allograft Rejection Gene Expression Observational Study (CARGO II) , 2012, Transplantation.

[113]  M. Eng,et al.  A review of the United States experience with combined heart‐liver transplantation , 2012, Transplant international : official journal of the European Society for Organ Transplantation.

[114]  M. Dew,et al.  Predictors and Outcomes of Health‐Related Quality of Life in Caregivers of Cardiothoracic Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[115]  C. Maiello,et al.  Pulmonary artery hypertension in heart transplant recipients: how much is too much? , 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[116]  S. Hunt,et al.  Clinical and Functional Correlates of Early Microvascular Dysfunction After Heart Transplantation , 2012, Circulation. Heart failure.

[117]  E. Greanya,et al.  Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past , 2012, Transplant infectious disease : an official journal of the Transplantation Society.

[118]  Howard K. Song,et al.  Impact of single-ventricle physiology on death after heart transplantation in adults with congenital heart disease. , 2012, The Annals of thoracic surgery.

[119]  O. Viklicky,et al.  Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation. , 2012, Journal of the American Society of Nephrology : JASN.

[120]  D. Mancini,et al.  Randomized Controlled Trial of Sirolimus Conversion in Cardiac Transplant Recipients With Renal Insufficiency , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[121]  E. Decullier,et al.  Sirolimus and secondary skin-cancer prevention in kidney transplantation. , 2012, The New England journal of medicine.

[122]  J. Cowger,et al.  Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejection. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[123]  G. Stevens,et al.  Outcomes of cardiac transplantation in septuagenarians. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[124]  K. Dimopoulos,et al.  Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life--single centre experience and review of published data. , 2012, European heart journal.

[125]  N. Chou,et al.  Endomyocardial biopsy in heart transplantation: schedule or event? , 2012, Transplantation proceedings.

[126]  Y. Toyoda,et al.  Heart transplantation for adults with congenital heart disease: results in the modern era. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[127]  S. Schrier,et al.  Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategies. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[128]  G. Salles,et al.  Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. , 2012, The Lancet. Oncology.

[129]  E. Reed,et al.  Reduction of alloantibodies via proteasome inhibition in cardiac transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[130]  J. Saucedo,et al.  Abdominal aortic aneurysms (AAA) post heart transplantation: a systematic review of literature. , 2011, Annals of Transplantation.

[131]  M. Konstam,et al.  Outcomes in patients with symptomatic cerebrovascular disease undergoing heart transplantation. , 2011, Journal of the American College of Cardiology.

[132]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[133]  Fiona O'Reilly Zwald,et al.  Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. , 2011, Journal of the American Academy of Dermatology.

[134]  H. Bøtker,et al.  Effect of Everolimus Introduction on Cardiac Allograft Vasculopathy—Results of a Randomized, Multicenter Trial , 2011, Transplantation.

[135]  L. Kucirka,et al.  Desensitization in HLA-incompatible kidney recipients and survival. , 2011, The New England journal of medicine.

[136]  J. Saucedo,et al.  Drug eluting versus bare metal stents in cardiac allograft vasculopathy , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[137]  A. Kfoury,et al.  Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[138]  A. Angelini,et al.  Report from a consensus conference on antibody-mediated rejection in heart transplantation. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[139]  R. Davies,et al.  Listing and Transplanting Adults With Congenital Heart Disease , 2011, Circulation.

[140]  E. Tay,et al.  Comprehensive Use of Cardiopulmonary Exercise Testing Identifies Adults With Congenital Heart Disease at Increased Mortality Risk in the Medium Term , 2012, Circulation.

[141]  H. Katus,et al.  Malignancies after heart transplantation: incidence, risk factors, and effects of calcineurin inhibitor withdrawal. , 2010, Transplantation proceedings.

[142]  A. Boyle,et al.  Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices. , 2010, The Journal of thoracic and cardiovascular surgery.

[143]  R. Delgado-Mederos,et al.  Cerebrovascular Complications After Heart Transplantation , 2010, Current cardiology reviews.

[144]  R. Ohye,et al.  A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. , 2010, The Journal of thoracic and cardiovascular surgery.

[145]  M. Farrero,et al.  Therapy with sildenafil or bosentan decreases pulmonary vascular resistance in patients ineligible for heart transplantation because of severe pulmonary hypertension. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[146]  D. Abramowicz,et al.  The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[147]  A. Caliendo,et al.  The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation , 2010, Transplantation.

[148]  A. Cribier,et al.  Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[149]  M. Oz,et al.  The Effect of Body Mass Index on Survival Following Heart Transplantation: Do Outcomes Support Consensus Guidelines? , 2010, Annals of surgery.

[150]  S. Russell,et al.  Impact of recipient body mass index on organ allocation and mortality in orthotopic heart transplantation. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[151]  S. Russell,et al.  Heart transplantation for adults with congenital heart disease: analysis of the United network for organ sharing database. , 2009, The Annals of thoracic surgery.

[152]  P. Hendry,et al.  Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary. , 2009, The Canadian journal of cardiology.

[153]  G. Guyatt,et al.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.

[154]  W. Kremers,et al.  Effect of neurologic complications on outcome after heart transplant. , 2008, Archives of neurology.

[155]  B. Sivertsen,et al.  Depressive Symptoms and All-Cause Mortality After Heart Transplantation , 2007, Transplantation.

[156]  P. Macdonald,et al.  Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation , 2007, European journal of heart failure.

[157]  J. Shuhaiber,et al.  Comparison of survival in primary and repeat heart transplantation from 1987 through 2004 in the United States. , 2007, The Annals of thoracic surgery.

[158]  D. Renlund,et al.  Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[159]  J. Wald,et al.  Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin , 2006, Clinical transplantation.

[160]  Ross T Tsuyuki,et al.  Validity and reliability of the Edmonton Frail Scale , 2006, Age and ageing.

[161]  M. Fishbein,et al.  Acute antibody-mediated rejection of cardiac transplants. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[162]  K. Groshart,et al.  Treatment of vascular rejection with rituximab in cardiac transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[163]  W. Mahle,et al.  Cardiac retransplantation in childhood: analysis of data from the United Network for Organ Sharing. , 2005, The Journal of thoracic and cardiovascular surgery.

[164]  A. Yeung,et al.  Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years. , 2005, Journal of the American College of Cardiology.

[165]  R. Starling,et al.  Brain natriuretic peptide levels do not correlate with acute cellular rejection in De Novo orthotopic heart transplant recipients. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[166]  J. Martí-Fàbregas,et al.  Cerebrovascular Disease as a Complication of Cardiac Transplantation , 2005, Cerebrovascular Diseases.

[167]  R. Pierson,et al.  Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[168]  M. Dew,et al.  Onset, timing and risk for depression and anxiety in family caregivers to heart transplant recipients , 2004, Psychological Medicine.

[169]  T. del Ser,et al.  [Neurological complications in a series of 205 orthotopic heart transplant patients]. , 2004, Revista de neurologia.

[170]  J. Kobashigawa,et al.  Retransplantation in 7,290 primary transplant patients: a 10-year multi-institutional study. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[171]  M. Carrier,et al.  2001 Canadian Cardiovascular Society Consensus Conference on cardiac transplantation. , 2003, The Canadian journal of cardiology.

[172]  M. Gómez-Sánchez,et al.  Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[173]  P. McCarthy,et al.  Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[174]  E. Bouza,et al.  Pneumocystis carinii infection in heart transplant recipients. Efficacy of a weekend prophylaxis schedule. , 1997, Medicine.

[175]  L. Erdoes,et al.  Prospective evaluation of peripheral vascular disease in heart transplant recipients. , 1995, Journal of vascular surgery.

[176]  L. Yeatman,et al.  Effect of pravastatin on outcomes after cardiac transplantation. , 1995, The New England journal of medicine.

[177]  K. Phan,et al.  Outcomes and survival following heart retransplantation for cardiac allograft failure: a systematic review and meta-analysis. , 2018, Annals of cardiothoracic surgery.

[178]  J. Tobias,et al.  Posttransplant lymphoproliferative disease and survival in adult heart transplant recipients. , 2017, Journal of cardiology.

[179]  L. Lund,et al.  The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Heart Transplantation Report-2017; Focus Theme: Allograft ischemic time. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[180]  M. Hannan,et al.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[181]  G. Gerosa,et al.  Posttraumatic stress disorder and depression in heart transplantation recipients: the relationship with outcome and adherence to medical treatment. , 2011, General hospital psychiatry.

[182]  E. Reed,et al.  The long‐term outcome of treated sensitized patients who undergo heart transplantation , 2011, Clinical transplantation.

[183]  E. L. Prak,et al.  Antibody-mediated rejection in heart transplant recipients: potential efficacy of B-cell depletion and antibody removal. , 2006, Clinical transplants.